279 related articles for article (PubMed ID: 12010622)
21. Potential options to optimize therapy of gastroesophageal reflux disease with proton pump inhibitors.
Tonini M; Vigneri S; Neri M; Cuomo R; Savarino V; Pace F
Digestion; 2007; 76(3-4):171-8. PubMed ID: 18046084
[TBL] [Abstract][Full Text] [Related]
22. Lack of correlation between gastroesophageal reflux disease symptoms and esophageal lesions after sleeve gastrectomy.
Soricelli E; Casella G; Baglio G; Maselli R; Ernesti I; Genco A
Surg Obes Relat Dis; 2018 Jun; 14(6):751-756. PubMed ID: 29571635
[TBL] [Abstract][Full Text] [Related]
23. Esomeprazole magnesium (Nexium).
Baker DE
Rev Gastroenterol Disord; 2001; 1(1):32-41. PubMed ID: 12120118
[TBL] [Abstract][Full Text] [Related]
24. Healing of Erosive Esophagitis and Improvement of Symptoms of Gastroesophageal Reflux Disease After Esomeprazole Treatment in Children 12 to 36 Months Old.
Tolia V; Gilger MA; Barker PN; Illueca M
J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S31-6. PubMed ID: 26422096
[TBL] [Abstract][Full Text] [Related]
25. Management strategies for gastroesophageal reflux disease.
Bak YT
J Gastroenterol Hepatol; 2004 Sep; 19 Suppl 3():S49-53. PubMed ID: 15324382
[TBL] [Abstract][Full Text] [Related]
26. Poor effectiveness of proton pump inhibitors in non-erosive reflux disease: the truth in the end!
Scarpignato C
Neurogastroenterol Motil; 2012 Aug; 24(8):697-704. PubMed ID: 22783985
[TBL] [Abstract][Full Text] [Related]
27. Healing of Erosive Esophagitis and Improvement of Symptoms of Gastroesophageal Reflux Disease After Esomeprazole Treatment in Children 12 to 36 Months Old.
Tolia V; Gilger MA; Barker PN; Illueca M
J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S31-6. PubMed ID: 26121348
[TBL] [Abstract][Full Text] [Related]
28. Characteristics of refractory gastroesophageal reflux disease (GERD) symptoms -is switching proton pump inhibitors based on the patient's CYP2C19 genotype an effective management strategy?
Takeuchi T; Oota K; Harada S; Edogawa S; Kojima Y; Sanomura M; Sakaguchi M; Hayashi K; Hongoh Y; Itabashi T; Kitae H; Hoshimoto M; Takeuchi N; Higuchi K
Intern Med; 2015; 54(2):97-105. PubMed ID: 25742999
[TBL] [Abstract][Full Text] [Related]
29. Pharmacologic treatment of GERD: Where we are now, and where are we going?
Scarpignato C; Hongo M; Wu JCY; Lottrup C; Lazarescu A; Stein E; Hunt RH
Ann N Y Acad Sci; 2020 Dec; 1482(1):193-212. PubMed ID: 32935346
[TBL] [Abstract][Full Text] [Related]
30. Proton pump inhibitors in the management of gastroesophageal reflux disease.
Hrelja N; Zerem E
Med Arh; 2011; 65(1):52-5. PubMed ID: 21534455
[TBL] [Abstract][Full Text] [Related]
31. Esomeprazole: a review of its use in the management of acid-related disorders.
Scott LJ; Dunn CJ; Mallarkey G; Sharpe M
Drugs; 2002; 62(10):1503-38. PubMed ID: 12093317
[TBL] [Abstract][Full Text] [Related]
32. Management of symptoms in step-down therapy of gastroesophageal reflux disease.
Mine S; Iida T; Tabata T; Kishikawa H; Tanaka Y
J Gastroenterol Hepatol; 2005 Sep; 20(9):1365-70. PubMed ID: 16105122
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial.
Richter JE; Kahrilas PJ; Johanson J; Maton P; Breiter JR; Hwang C; Marino V; Hamelin B; Levine JG;
Am J Gastroenterol; 2001 Mar; 96(3):656-65. PubMed ID: 11280530
[TBL] [Abstract][Full Text] [Related]
34. Drugs, bugs, and esophageal pH profiles.
Robinson M
Yale J Biol Med; 1999; 72(2-3):169-72. PubMed ID: 10780578
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of esomeprazole in controlling reflux symptoms, intraesophageal, and intragastric pH in patients with Barrett's esophagus.
Yeh RW; Gerson LB; Triadafilopoulos G
Dis Esophagus; 2003; 16(3):193-8. PubMed ID: 14641308
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of lansoprazole in adolescents with symptomatic erosive and non-erosive gastroesophageal reflux disease.
Fiedorek S; Tolia V; Gold BD; Huang B; Stolle J; Lee C; Gremse D
J Pediatr Gastroenterol Nutr; 2005 Mar; 40(3):319-27. PubMed ID: 15735486
[TBL] [Abstract][Full Text] [Related]
37. Proton pump inhibitors in pediatrics: evaluation of efficacy in GERD therapy.
Romano C; Chiaro A; Comito D; Loddo I; Ferrau V
Curr Clin Pharmacol; 2011 Feb; 6(1):41-7. PubMed ID: 21235462
[TBL] [Abstract][Full Text] [Related]
38. Lansoprazole heals erosive reflux oesophagitis in patients with Barrett's oesophagus.
Sontag SJ; Schnell TG; Chejfec G; Kurucar C; Karpf J; Levine G
Aliment Pharmacol Ther; 1997 Feb; 11(1):147-56. PubMed ID: 9042987
[TBL] [Abstract][Full Text] [Related]
39. The Effect of Proton Pump Inhibitors on Barrett's Esophagus.
Dunbar KB; Souza RF; Spechler SJ
Gastroenterol Clin North Am; 2015 Jun; 44(2):415-24. PubMed ID: 26021202
[TBL] [Abstract][Full Text] [Related]
40. A review of esomeprazole in the treatment of gastroesophageal reflux disease (GERD).
Kalaitzakis E; Björnsson E
Ther Clin Risk Manag; 2007 Aug; 3(4):653-63. PubMed ID: 18472988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]